113 related articles for article (PubMed ID: 3512620)
1. Enhancement of the antiemetic action of metoclopramide against cisplatin-induced emesis by transdermal electrical nerve stimulation.
Saller R; Hellenbrecht D; Bühring M; Hess H
J Clin Pharmacol; 1986 Feb; 26(2):115-9. PubMed ID: 3512620
[TBL] [Abstract][Full Text] [Related]
2. Prochlorperazine and transdermal scopolamine added to a metoclopramide antiemetic regimen. A controlled comparison.
Malone JM; Christensen CW; Yashinsky D; Malviya VK; Deppe G
J Reprod Med; 1990 Oct; 35(10):932-4. PubMed ID: 2246759
[TBL] [Abstract][Full Text] [Related]
3. Control of cisplatin-induced delayed emesis with metoclopramide and dexamethasone: a randomized controlled trial.
Shinkai T; Saijo N; Eguchi K; Sasaki Y; Tamura T; Fujiwara Y; Mae M; Fukuda M; Ohe Y; Sasaki S
Jpn J Clin Oncol; 1989 Mar; 19(1):40-4. PubMed ID: 2921817
[TBL] [Abstract][Full Text] [Related]
4. The antiemetic activity of high-dose alizapride and high-dose metoclopramide in patients receiving cancer chemotherapy: a prospective, randomized, double-blind trial.
Joss RA; Galeazzi RL; Bischoff AK; Pirovino M; Ryssel HJ; Brunner KW
Clin Pharmacol Ther; 1986 Jun; 39(6):619-24. PubMed ID: 3519041
[TBL] [Abstract][Full Text] [Related]
5. [A randomized controlled trial of acute and delayed cisplatin-induced emesis with metoclopramide, dexamethasone and prochlorperazine].
Nino S; Umehara H; Inoue I; Tamura T; Sasaki Y; Sakurai M; Shinkai T; Eguchi K; Saijo N; Suemasu K
Gan To Kagaku Ryoho; 1987 Oct; 14(10):2881-4. PubMed ID: 3310905
[TBL] [Abstract][Full Text] [Related]
6. The effect of administration rate on cisplatin-induced emesis.
Jordan NS; Schauer PK; Schauer A; Nightingale C; Golub G; Martin RS; Williams HM
J Clin Oncol; 1985 Apr; 3(4):559-61. PubMed ID: 3884747
[TBL] [Abstract][Full Text] [Related]
7. Ondansetron + dexamethasone vs metoclopramide + dexamethasone + diphenhydramine in prevention of cisplatin-induced emesis. Italian Group For Antiemetic Research.
Lancet; 1992 Jul; 340(8811):96-9. PubMed ID: 1352024
[TBL] [Abstract][Full Text] [Related]
8. Maintenance of antiemetic effect of a metoclopramide-dexamethasone combination during subsequent cisplatin courses.
Cognetti F; Carlini P; Pinnarò P; Ruggeri EM; Caporali C
Oncology; 1986; 43(5):292-4. PubMed ID: 3763123
[TBL] [Abstract][Full Text] [Related]
9. Antiemetic efficacy of high-dose metoclopramide: randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting.
Gralla RJ; Itri LM; Pisko SE; Squillante AE; Kelsen DP; Braun DW; Bordin LA; Braun TJ; Young CW
N Engl J Med; 1981 Oct; 305(16):905-9. PubMed ID: 7024807
[TBL] [Abstract][Full Text] [Related]
10. A randomized, multicenter study comparing the efficacy and tolerability of tropisetron, a new 5-HT3 receptor antagonist, with a metoclopramide-containing antiemetic cocktail in the prevention of cisplatin-induced emesis.
Sorbe BG; Högberg T; Glimelius B; Schmidt M; Wernstedt L; Hansen O; Sörensen BT; Räisänen I; van Oosterom AT; de Bruijn KM
Cancer; 1994 Jan; 73(2):445-54. PubMed ID: 8293412
[TBL] [Abstract][Full Text] [Related]
11. [Benefit and risk of high-dose metoclopramide in comparison to high-dose haloperidol or triflupromazine in cisplatin-induced vomiting].
Saller R; Hellenbrecht D
Klin Wochenschr; 1985 May; 63(9):428-32. PubMed ID: 4039775
[TBL] [Abstract][Full Text] [Related]
12. A randomized, double-blind comparison of the antiemetic effect of metoclopramide and lorazepam with or without dexamethasone in patients receiving high-dose cisplatin.
Stephens SH; Silvey VL; Wheeler RH
Cancer; 1990 Aug; 66(3):443-6. PubMed ID: 2194642
[TBL] [Abstract][Full Text] [Related]
13. High-dose metoclopramide by infusion: a double-blind study of plasma concentration-effect relationships in patients receiving cancer chemotherapy.
Taylor WB; Simpson JM; Bateman DN
Eur J Clin Pharmacol; 1987; 33(2):161-5. PubMed ID: 3319642
[TBL] [Abstract][Full Text] [Related]
14. Antiemetic combination for cisplatin-induced emesis. Results from a controlled study.
Martín Jiménez M; Diaz-Rubio E
Bull Cancer; 1986; 73(3):294-8. PubMed ID: 3756365
[TBL] [Abstract][Full Text] [Related]
15. Emesis due to cancer chemotherapy: results of a prospective, randomised, double-blind trial of varying doses of metoclopramide in the management of cis-platinum-induced vomiting.
Allan SG; Cornbleet MA; Lockhart SP; Warrington PS; Leonard RC; Smyth JF
Eur J Cancer Clin Oncol; 1984 Dec; 20(12):1481-4. PubMed ID: 6389147
[TBL] [Abstract][Full Text] [Related]
16. Phase III double-blind comparison of intravenous ondansetron and metoclopramide as antiemetic therapy for patients receiving multiple-day cisplatin-based chemotherapy.
Sledge GW; Einhorn L; Nagy C; House K
Cancer; 1992 Nov; 70(10):2524-8. PubMed ID: 1423181
[TBL] [Abstract][Full Text] [Related]
17. Antiemetic effects of metoclopramide (M) continuous infusion (CI): safety, efficacy, patient preference, and cost reduction.
Presant CA; Wiseman C; Gala K; Kennedy P; Bouzaglou A; Blayney D; Schindler J; Rigas M; Melville J; Dolan J
Prog Clin Biol Res; 1987; 248():299-302. PubMed ID: 3671417
[No Abstract] [Full Text] [Related]
18. Improved benefit/risk ratio of higher-dose metoclopramide therapy during cisplatin-induced emesis.
Saller R; Hellenbrecht D; Hellstern A; Hess H
Eur J Clin Pharmacol; 1985; 29(3):311-2. PubMed ID: 4076327
[TBL] [Abstract][Full Text] [Related]
19. The role of metoclopramide in acute and delayed chemotherapy induced emesis: a randomised double blind trial.
O'Brien ME; Cullen MH; Woodroffe C; Kelly K; Burman C; Palmer K; Stuart NS; Blackledge GR; Sharpe J
Br J Cancer; 1989 Nov; 60(5):759-63. PubMed ID: 2679853
[TBL] [Abstract][Full Text] [Related]
20. A comparison of the antiemetic efficacy of prochlorperazine and metoclopramide for the treatment of cisplatin-induced emesis: a prospective, randomized, double-blind study.
Carr BI; Bertrand M; Browning S; Doroshow JH; Presant C; Pulone B; Hill LR
J Clin Oncol; 1985 Aug; 3(8):1127-32. PubMed ID: 4040552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]